Elanco Animal Health (ELAN) Other Operating Expenses (2017 - 2026)
Elanco Animal Health (ELAN) reported Other Operating Expenses of -$9.0 million for Q1 2026, up 25.0% on a YoY basis from -$7.2 million in Q1 2025, and down 325.0% sequentially from $4.0 million in Q4 2025.
Elanco Animal Health (ELAN) Other Operating Expenses (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Other Operating Expenses data on file, last reported at -$9.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Operating Expenses rose 25.0% year-over-year to -$9.0 million; the trailing twelve-month figure through Mar 2026 stood at -$16.0 million (up 23.81% YoY), and the FY2025 full-year result was -$19.0 million, down 5.56% from the prior year.
- Other Operating Expenses fell to -$9.0 million in Q1 2026, from $4.0 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $707.0 million in Q1 2022 to a low of -$647.0 million in Q4 2024.
- A 5-year average of $288.3 million and a median of $322.0 million in 2024 frame the typical range for Other Operating Expenses.
- Peak annual rise in Other Operating Expenses reached 100.62% in 2025, while the deepest fall reached 450.0% in 2025.
- Tracing ELAN's Other Operating Expenses over 5 years: stood at $661.0 million in 2022, then advanced by 0.91% to $667.0 million in 2023, then sank by 197.0% to -$647.0 million in 2024, then soared by 100.62% to $4.0 million in 2025, then sank by 325.0% to -$9.0 million in 2026.
- Business Quant data shows ELAN's Other Operating Expenses at -$9.0 million in Q1 2026, $4.0 million in Q4 2025, and -$11.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Jun 30, 2025 | -11.00 Mn |
| Mar 31, 2025 | -12.00 Mn |
| Dec 31, 2024 | -647.00 Mn |
| Sep 30, 2024 | 640.00 Mn |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -9.00 Mn |
| Jun 30, 2023 | 667.00 Mn |
| Mar 31, 2023 | 701.00 Mn |
| Dec 31, 2022 | 661.00 Mn |
| Sep 30, 2022 | 668.00 Mn |
| Jun 30, 2022 | 678.00 Mn |
| Mar 31, 2022 | 707.00 Mn |
| Dec 31, 2021 | 702.00 Mn |
| Sep 30, 2021 | 714.00 Mn |
| Jun 30, 2021 | 731.00 Mn |
| Mar 31, 2021 | 776.00 Mn |
| Dec 31, 2020 | 803.70 Mn |
| Sep 30, 2020 | 471.00 Mn |